Alzheimer’s Research UK (ARUK) have released a brief report on six research priorities, which are:
- Achieving earlier detection of diseases which may cause dementia, (ideally by 10-15 years), to enhance development of new treatments / interventions for people most at risk of developing dementia.
- Developing novel validated targets in early drug development to maximise chances of successful clinical trials.
- Ensuring the UK is the best place to conduct clinical dementia research.
- Expanding the research infrastructure; maintaining the UK’s position as a world leader in dementia research.
- Improving dementia risk reduction and prevention, in the context of multi-morbidities.
- Developing robust prevalence data for dementia; increasing knowledge of the societal impact of dementia.
The overall aim is to deliver life-changing treatment(s) for dementia by doubling research funding and investing in trials for new treatments.
Delivering the dementia moonshot: a plan to find life-changing treatments. Cambridge: Alzheimer’s Research UK, January 2020.
An earlier related report:
No time to lose: an action plan for dementia. Cambridge: Alzheimer’s Research UK, September 2018.